A Phase I/II Study to Evaluate the Safety and Efficacy of the Allogeneic Injection of Expanded Adipose-derived Stem Cells to Patients With Knee Osteoarthritis

Trial Profile

A Phase I/II Study to Evaluate the Safety and Efficacy of the Allogeneic Injection of Expanded Adipose-derived Stem Cells to Patients With Knee Osteoarthritis

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Oct 2016

At a glance

  • Drugs Adipose-derived stem cells-UnicoCell (Primary) ; Hyaluronic acid
  • Indications Osteoarthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors UnicoCell Biomed
  • Most Recent Events

    • 21 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top